MARCI KLEINROCK: Open Payments
NPI 1851709117 · NASHVILLE, TN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$13,206 in 156 payments from 24 companies in 2025. Trend: 2023 $15,153 · 2024 $3,489 · 2025 $13,206
Consulting: $6,620Food & beverage: $4,126Speaker / faculty: $2,200Education: $253Travel & lodging: $7
| Company | Payments | Amount |
|---|---|---|
| UCB, Inc. | 32 | $3,293 |
| Solta Medical, a division of Bausch Health US, LLC | 3 | $2,230 |
| Incyte Corporation | 13 | $2,051 |
| Novartis Pharmaceuticals Corporation | 19 | $1,861 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 7 | $1,403 |
| Janssen Biotech, Inc. | 19 | $592 |
| Galderma Laboratories, L.P. | 14 | $409 |
| ABBVIE INC. | 16 | $390 |
| Organon LLC | 7 | $184 |
| Janssen Scientific Affairs, LLC | 1 | $140 |
Products named: Bimzelx, Winlevi, TREMFYA, SKYRIZI, NEMLUVIO, DUPIXENT, OPZELURA, Rhapsido.
Industry payments across TN — which companies pay providers there.
